Mechanisms Regulating Reduced c-Kit-Dependent EAE Susceptibility in Male SJL Mice
雄性 SJL 小鼠 c-Kit 依赖性 EAE 易感性降低的调节机制
基本信息
- 批准号:8431165
- 负责人:
- 金额:$ 23.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:Abnormal coordinationAdoptive TransferAffectAgeAllergicAnimal ModelAttenuatedAutoimmune DiseasesAutoimmune ProcessBladderBlood - brain barrier anatomyBrain regionCD8B1 geneCellsCentral Nervous System DiseasesDefectDemyelinationsDevelopmentDiseaseDisease ProgressionDisease susceptibilityEnvironmentEventExhibitsExperimental Autoimmune EncephalomyelitisFemaleGenderGenesGeneticGonadal Steroid HormonesHormonalHormonesImmuneImmune responseImmunizationIncontinenceInflammationInflammatoryInflammatory ResponseInterruptionIntestinesInvestigationLaboratoriesLeadLinkLymphoidMediatingMediator of activation proteinMeningesModelingMolecularMotorMouse StrainsMultiple SclerosisMusMutant Strains MiceMutationMyelinNatureNerve FibersNervous System TraumaNeuraxisNeurologicOrganPathologicPatientsPeripheralPhenotypePlayPopulationPredispositionPregnancyPrevalenceProcessProto-Oncogene Protein c-kitRecruitment ActivityRelapseRodent ModelRoleSJL MouseSensorySerumSeverity of illnessSex BiasSignal TransductionSiteSpinal CordStem Cell FactorSystemT-LymphocyteTestosteroneTimeTissuesVisualbasecell typegranulocytehuman diseaselate disease onsetmalemast cellmastocytosismutantneuroprotectionprotective effectreconstitutionresponsesextrafficking
项目摘要
DESCRIPTION (provided by applicant): Multiple sclerosis (MS), the most common inflammatory disease of the central nervous system (CNS), affects more than 2.5 million people worldwide. MS is characterized by perivascular inflammation in the CNS, demyelination of nerve fibers as well as axonal damage. The resulting interruption of motor and sensory impulses as they pass through demyelinated regions of the brain or spinal cord often leads to visual disturbances, incontinence as well as sensory and motor disturbances. The prevalence of this disease is estimated to be at least three times greater in females than males and while genetic, hormonal and immune response differences have been implicated, the basis for this gender bias is still not fully understood. MS is considered to be autoimmune in nature and myelin-specific CD4+ Th1 and Th17 cells are major orchestrators of the CNS inflammation. It is assumed that these cells are initially activated in peripheral lymphoid organs but must cross the relatively impermeable blood-brain barrier (BBB) to become reactivated in the CNS. Other innate immune cells that infiltrate or reside in the CNS contribute to inflammation-mediated neurological damage. Many of these events have been initially defined by studying the similar, albeit imperfect rodent model of MS, experimental allergic/autoimmune encephalomyelitis (EAE). Mast cells are granulocytes that reside in most tissues and are among the innate cells that exert an important amplifying effect on disease severity in females. Mice bearing mutations in Kit, which encodes the SCF receptor, ckit, fail to develop mast cells and have been used to study the role of mast cells in a relapsing-remitting EAE model. We previously demonstrated that female SJLW/Wv mice exhibit attenuated EAE, a phenotype dependent on mast cells. However, male SJLW/Wv mice have exacerbated disease, indicating either mast cells or other c-kit related defects are pathologic in males. This is not due to disparate serum testosterone levels between wild type and ckitW/Wv males, which show no significant differences. There are at least two explanations for these observations: i) Male mast cells, under the influence of sex hormones such as testosterone, show distinct responses in the context of disease compared to female mast cells; and/or ii) SCF, the ligand for c-kit, exerts a neuroprotective effect in concert
with testosterone that acts to minimize immune-mediated damage in the CNS. The specific aims of this study are: 1) Compare the events (e.g. T cell priming in the periphery, inflammatory cell entry to the CNS, local CNS inflammatory responses) that lead to development of EAE in wild type versus ckitW/Wv male mice to determine where c-kit signals exert their protective influence 2)
Identify whether and how mast cells or other c-kit related factors alter disease susceptibility in males.
PUBLIC HEALTH RELEVANCE: It is still not understood why males are generally less susceptible to autoimmune disease than females. We observed that mutations in the Kit gene (c-kitW/Wv), the receptor for stem cell factor, protect females from developing severe disease in a
rodent model of multiple sclerosis, but exacerbate disease in males. These mice provide a perfect system to explore the how c-kit signaling, in concert with influences from male sex hormones, confers neuroprotection and may lead to better therapies for this devastating CNS disease.
描述(由申请人提供):多发性硬化症 (MS) 是中枢神经系统 (CNS) 最常见的炎症性疾病,影响全球超过 250 万人。 MS 的特征是中枢神经系统血管周围炎症、神经纤维脱髓鞘以及轴突损伤。当运动和感觉冲动通过大脑或脊髓的脱髓鞘区域时,由此产生的中断通常会导致视觉障碍、失禁以及感觉和运动障碍。据估计,这种疾病在女性中的患病率至少是男性的三倍,虽然遗传、激素和免疫反应差异已被证实,但这种性别偏见的基础仍不完全清楚。 MS 被认为本质上是自身免疫性的,髓磷脂特异性 CD4+ Th1 和 Th17 细胞是中枢神经系统炎症的主要协调者。据推测,这些细胞最初在外周淋巴器官中被激活,但必须穿过相对不可渗透的血脑屏障(BBB)才能在中枢神经系统中重新激活。其他浸润或驻留在中枢神经系统的先天免疫细胞会导致炎症介导的神经损伤。其中许多事件最初是通过研究相似但不完美的 MS 啮齿动物模型、实验性过敏/自身免疫性脑脊髓炎 (EAE) 来定义的。肥大细胞是存在于大多数组织中的粒细胞,是对女性疾病严重程度发挥重要放大作用的先天细胞之一。 Kit(编码 SCF 受体 ckit)携带突变的小鼠无法发育肥大细胞,并已被用来研究肥大细胞在复发缓解型 EAE 模型中的作用。我们之前证明雌性 SJLW/Wv 小鼠表现出减弱的 EAE,这是一种依赖肥大细胞的表型。然而,雄性 SJLW/Wv 小鼠的疾病加剧,表明肥大细胞或其他 c-kit 相关缺陷在雄性中是病理性的。这并不是因为野生型和 ckitW/Wv 雄性之间的血清睾酮水平不同,没有显示出显着差异。对于这些观察结果至少有两种解释: i) 与女性肥大细胞相比,男性肥大细胞在睾酮等性激素的影响下,在疾病背景下表现出不同的反应;和/或 ii) SCF(c-kit 的配体)协同发挥神经保护作用
睾酮可最大限度地减少中枢神经系统免疫介导的损伤。本研究的具体目的是: 1) 比较野生型与 ckitW/Wv 雄性小鼠中导致 EAE 发生的事件(例如外周 T 细胞启动、炎症细胞进入 CNS、局部 CNS 炎症反应),以确定 c-kit 信号在何处发挥其保护作用 2)
确定肥大细胞或其他 c-kit 相关因子是否以及如何改变男性的疾病易感性。
公共卫生相关性:目前尚不清楚为什么男性通常比女性更不易患自身免疫性疾病。我们观察到,干细胞因子受体 Kit 基因 (c-kitW/Wv) 的突变可以保护女性免于患上严重疾病。
多发性硬化症的啮齿动物模型,但会加剧雄性的疾病。这些小鼠提供了一个完美的系统来探索 c-kit 信号传导如何与男性性激素的影响相结合,赋予神经保护作用,并可能为这种毁灭性的中枢神经系统疾病带来更好的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melissa A Brown其他文献
(T)Betting on innate lymphoid cells in CNS inflammatory disease
(T)在中枢神经系统炎症性疾病中对固有淋巴细胞进行投注
- DOI:
10.1038/ni.3839 - 发表时间:
2017-09-19 - 期刊:
- 影响因子:27.600
- 作者:
Melissa A Brown;Abigail E Russi - 通讯作者:
Abigail E Russi
MASTering the immune response: mast cells in autoimmunity.
掌握免疫反应:自身免疫中的肥大细胞。
- DOI:
10.1002/9780470033449.ch18 - 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
Gregory D. Gregory;Allison L. Bickford;Michaela Robbie;M. Tanzola;Melissa A Brown - 通讯作者:
Melissa A Brown
Vascular and Capillary Endothelium
血管和毛细血管内皮
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
Melissa A Brown;C. S. Wallace;G. Truskey - 通讯作者:
G. Truskey
HEMATOPOIESIS AND STEM CELLS Ikaros limits basophil development by suppressing C/EBP- a expression
造血和干细胞 Ikaros 通过抑制 C/EBP-a 表达来限制嗜碱性粒细胞发育
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
K. Rao;C. Smuda;Gregory D. Gregory;B. Min;Melissa A Brown - 通讯作者:
Melissa A Brown
No DL1 Notch ligand? GATA be a mast cell
没有 DL1 Notch 配体?
- DOI:
10.1038/ni0807-796 - 发表时间:
2007 - 期刊:
- 影响因子:30.5
- 作者:
S. Winandy;Melissa A Brown - 通讯作者:
Melissa A Brown
Melissa A Brown的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melissa A Brown', 18)}}的其他基金
Distinct mast cell responses in male and female SJL mice underlie sex dimorphic EAE susceptibility
雄性和雌性 SJL 小鼠不同的肥大细胞反应是性别二态性 EAE 易感性的基础
- 批准号:
10176381 - 财政年份:2017
- 资助金额:
$ 23.18万 - 项目类别:
Mechanisms Regulating Reduced c-Kit-Dependent EAE Susceptibility in Male SJL Mice
雄性 SJL 小鼠 c-Kit 依赖性 EAE 易感性降低的调节机制
- 批准号:
8536427 - 财政年份:2012
- 资助金额:
$ 23.18万 - 项目类别:
Ikaros in mast vs. basophil lineage choice
肥大与嗜碱性粒细胞谱系选择中的 Ikaros
- 批准号:
7876311 - 财政年份:2010
- 资助金额:
$ 23.18万 - 项目类别:
Ikaros regulates T helper cell fate decisions
Ikaros 调节 T 辅助细胞的命运决定
- 批准号:
8086019 - 财政年份:2010
- 资助金额:
$ 23.18万 - 项目类别:
Ikaros in mast vs. basophil lineage choice
肥大与嗜碱性粒细胞谱系选择中的 Ikaros
- 批准号:
8072709 - 财政年份:2010
- 资助金额:
$ 23.18万 - 项目类别:
Mast cell regulation of CD8+ T cell responses
肥大细胞对 CD8 T 细胞反应的调节
- 批准号:
7393034 - 财政年份:2007
- 资助金额:
$ 23.18万 - 项目类别:
Mast cell regulation of CD8+ T cell responses
肥大细胞对 CD8 T 细胞反应的调节
- 批准号:
7487513 - 财政年份:2007
- 资助金额:
$ 23.18万 - 项目类别:
Mechanisms of mast cell influence on EAE disease course
肥大细胞对EAE病程影响的机制
- 批准号:
7162626 - 财政年份:2006
- 资助金额:
$ 23.18万 - 项目类别:
Mechanisms of mast cell influence on EAE disease course
肥大细胞对EAE病程影响的机制
- 批准号:
7342452 - 财政年份:2006
- 资助金额:
$ 23.18万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 23.18万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 23.18万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 23.18万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 23.18万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 23.18万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 23.18万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 23.18万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 23.18万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 23.18万 - 项目类别: